2015 Round Table

Pharmacoeconomy & opportunities for the pharmaceutical sector

Treatments, accommodate existing local actors in a growing market and push. Need for the country to find a way to ensure regular access to innovative.

Government priorities, which currently include massive expansion of Algeria's domestic production capacity

Audience

Director General of Pharmacy, MOH, Dr. Hamou Hafed
Director General of Health, MOH, Pr. Mohamel l’Hadj
General Manager of PCH, M’hamed Ayad
Director General of Social Security, Djaouad Bourkaib & Dr. Mohamed Lamine Ghanem
Ministry of Industry
Senior management of companies & healthcare sector representative : Novo Nordisk, AstraZeneca, Clinica Group, Merck, ANPP, Deloitte, Sevier
Chambers of Commerce: CCIAF, USABC